Article Versions Notes

Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, Cornely OA, S. Perlin D, Lass-Flörl C, Hoenigl M on behalf of the ECMM Working Group Immunologic Markers for Treatment Monitoring and Diagnosis in Invasive Mold Infection. COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment. Journal of Fungi. 2020; 6(2):91. https://doi.org/10.3390/jof6020091

Arastehfar, Amir, Agostinho Carvalho, Frank L. van de Veerdonk, Jeffrey D. Jenks, Philipp Koehler, Robert Krause, Oliver A. Cornely, David S. Perlin, Cornelia Lass-Flörl, and Martin Hoenigl on behalf of the ECMM Working Group Immunologic Markers for Treatment Monitoring and Diagnosis in Invasive Mold Infection. 2020. "COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment" Journal of Fungi 6, no. 2: 91. https://doi.org/10.3390/jof6020091

Arastehfar, A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P., Krause, R., Cornely, O. A., S. Perlin, D., Lass-Flörl, C., & Hoenigl, M., on behalf of the ECMM Working Group Immunologic Markers for Treatment Monitoring and Diagnosis in Invasive Mold Infection. (2020). COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment. Journal of Fungi, 6(2), 91. https://doi.org/10.3390/jof6020091